Cargando…

A Wireless Neuroprosthesis for Patients with Drug-refractory Epilepsy: A Proof-of-Concept Study

Objective Acute or protracted cortical recording may be necessary for patients with drug-refractory epilepsy to identify the ictogenic regions before undergoing resection. Currently, these invasive recording techniques present certain limitations, one of which is the need for cables connecting the r...

Descripción completa

Detalles Bibliográficos
Autores principales: Romanelli, Pantaleo, Valiante, Taufik A, Seri, Stefano, Puttilli, Cosimo, Picciafuoco, Mauro, Jakobs, Martin, Lozano, Andres
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6834104/
https://www.ncbi.nlm.nih.gov/pubmed/31763091
http://dx.doi.org/10.7759/cureus.5868
_version_ 1783466419268091904
author Romanelli, Pantaleo
Valiante, Taufik A
Seri, Stefano
Puttilli, Cosimo
Picciafuoco, Mauro
Jakobs, Martin
Lozano, Andres
author_facet Romanelli, Pantaleo
Valiante, Taufik A
Seri, Stefano
Puttilli, Cosimo
Picciafuoco, Mauro
Jakobs, Martin
Lozano, Andres
author_sort Romanelli, Pantaleo
collection PubMed
description Objective Acute or protracted cortical recording may be necessary for patients with drug-refractory epilepsy to identify the ictogenic regions before undergoing resection. Currently, these invasive recording techniques present certain limitations, one of which is the need for cables connecting the recording electrodes placed in the intracranial space with external devices displaying the recorded electrocorticographic signals. This equates to a direct connection between the sterile intracranial space with the non-sterile environment. Due to the increasing likelihood of infections with time, subdural grids are typically removed a few days after implantation, a limiting factor in localizing the epileptogenic zone if seizures are not frequent enough to be captured within this time-frame. Furthermore, patients are bound to stay in the hospital, connected by the wires to the recording device, thus increasing substantially the treatment costs. To address some of the current shortcomings of invasive monitoring, we developed a neuroprosthesis made of a subdural silicone grid connected to a wireless transmitter allowing prolonged electrocorticografic recording and direct cortical stimulation. This device consists of a silicone grid with 128-platinum/iridium contacts, connected to an implantable case providing wireless recording and stimulation. The case also houses a wirelessly rechargeable battery for chronic long-term implants. We report the results of the first human proof-of-concept trial for wireless transmission of electrocorticographic recordings using a device suited for long-term implantation in three patients with drug-refractory epilepsy.  Methods Three patients with medically refractory epilepsy underwent the temporary intraoperative placement of the subdural grid connected to the wireless device for recording and transmission of electrocorticographic signals for a duration of five minutes before the conventional recording electrodes were placed or the ictal foci were resected. Results Wireless transmission of brain signals was successfully achieved. The wireless electrocorticographic signal was judged of excellent quality by a blinded neurophysiologist. Conclusions This preliminary experience reports the first successful placement of a wireless electrocorticographic recording device in humans. Long-term placement for prolonged wireless electrocorticographic recording in epilepsy patients will be the next step.
format Online
Article
Text
id pubmed-6834104
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-68341042019-11-24 A Wireless Neuroprosthesis for Patients with Drug-refractory Epilepsy: A Proof-of-Concept Study Romanelli, Pantaleo Valiante, Taufik A Seri, Stefano Puttilli, Cosimo Picciafuoco, Mauro Jakobs, Martin Lozano, Andres Cureus Neurology Objective Acute or protracted cortical recording may be necessary for patients with drug-refractory epilepsy to identify the ictogenic regions before undergoing resection. Currently, these invasive recording techniques present certain limitations, one of which is the need for cables connecting the recording electrodes placed in the intracranial space with external devices displaying the recorded electrocorticographic signals. This equates to a direct connection between the sterile intracranial space with the non-sterile environment. Due to the increasing likelihood of infections with time, subdural grids are typically removed a few days after implantation, a limiting factor in localizing the epileptogenic zone if seizures are not frequent enough to be captured within this time-frame. Furthermore, patients are bound to stay in the hospital, connected by the wires to the recording device, thus increasing substantially the treatment costs. To address some of the current shortcomings of invasive monitoring, we developed a neuroprosthesis made of a subdural silicone grid connected to a wireless transmitter allowing prolonged electrocorticografic recording and direct cortical stimulation. This device consists of a silicone grid with 128-platinum/iridium contacts, connected to an implantable case providing wireless recording and stimulation. The case also houses a wirelessly rechargeable battery for chronic long-term implants. We report the results of the first human proof-of-concept trial for wireless transmission of electrocorticographic recordings using a device suited for long-term implantation in three patients with drug-refractory epilepsy.  Methods Three patients with medically refractory epilepsy underwent the temporary intraoperative placement of the subdural grid connected to the wireless device for recording and transmission of electrocorticographic signals for a duration of five minutes before the conventional recording electrodes were placed or the ictal foci were resected. Results Wireless transmission of brain signals was successfully achieved. The wireless electrocorticographic signal was judged of excellent quality by a blinded neurophysiologist. Conclusions This preliminary experience reports the first successful placement of a wireless electrocorticographic recording device in humans. Long-term placement for prolonged wireless electrocorticographic recording in epilepsy patients will be the next step. Cureus 2019-10-09 /pmc/articles/PMC6834104/ /pubmed/31763091 http://dx.doi.org/10.7759/cureus.5868 Text en Copyright © 2019, Romanelli et al. http://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Neurology
Romanelli, Pantaleo
Valiante, Taufik A
Seri, Stefano
Puttilli, Cosimo
Picciafuoco, Mauro
Jakobs, Martin
Lozano, Andres
A Wireless Neuroprosthesis for Patients with Drug-refractory Epilepsy: A Proof-of-Concept Study
title A Wireless Neuroprosthesis for Patients with Drug-refractory Epilepsy: A Proof-of-Concept Study
title_full A Wireless Neuroprosthesis for Patients with Drug-refractory Epilepsy: A Proof-of-Concept Study
title_fullStr A Wireless Neuroprosthesis for Patients with Drug-refractory Epilepsy: A Proof-of-Concept Study
title_full_unstemmed A Wireless Neuroprosthesis for Patients with Drug-refractory Epilepsy: A Proof-of-Concept Study
title_short A Wireless Neuroprosthesis for Patients with Drug-refractory Epilepsy: A Proof-of-Concept Study
title_sort wireless neuroprosthesis for patients with drug-refractory epilepsy: a proof-of-concept study
topic Neurology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6834104/
https://www.ncbi.nlm.nih.gov/pubmed/31763091
http://dx.doi.org/10.7759/cureus.5868
work_keys_str_mv AT romanellipantaleo awirelessneuroprosthesisforpatientswithdrugrefractoryepilepsyaproofofconceptstudy
AT valiantetaufika awirelessneuroprosthesisforpatientswithdrugrefractoryepilepsyaproofofconceptstudy
AT seristefano awirelessneuroprosthesisforpatientswithdrugrefractoryepilepsyaproofofconceptstudy
AT puttillicosimo awirelessneuroprosthesisforpatientswithdrugrefractoryepilepsyaproofofconceptstudy
AT picciafuocomauro awirelessneuroprosthesisforpatientswithdrugrefractoryepilepsyaproofofconceptstudy
AT jakobsmartin awirelessneuroprosthesisforpatientswithdrugrefractoryepilepsyaproofofconceptstudy
AT lozanoandres awirelessneuroprosthesisforpatientswithdrugrefractoryepilepsyaproofofconceptstudy
AT romanellipantaleo wirelessneuroprosthesisforpatientswithdrugrefractoryepilepsyaproofofconceptstudy
AT valiantetaufika wirelessneuroprosthesisforpatientswithdrugrefractoryepilepsyaproofofconceptstudy
AT seristefano wirelessneuroprosthesisforpatientswithdrugrefractoryepilepsyaproofofconceptstudy
AT puttillicosimo wirelessneuroprosthesisforpatientswithdrugrefractoryepilepsyaproofofconceptstudy
AT picciafuocomauro wirelessneuroprosthesisforpatientswithdrugrefractoryepilepsyaproofofconceptstudy
AT jakobsmartin wirelessneuroprosthesisforpatientswithdrugrefractoryepilepsyaproofofconceptstudy
AT lozanoandres wirelessneuroprosthesisforpatientswithdrugrefractoryepilepsyaproofofconceptstudy